This article will review the embryological development of the testicles. However, to understand the embryology of the testicles, it is essential to have a basic understanding of the normal anatomy of the testicles. The male gonads, otherwise known as the testicles, are sex glands that have both an exocrine secretory function in the production of sperm and an endocrinological function as part of the hypothalamic-pituitary-gonadal axis in men through the production of androgens. The normal anatomy of the testicles is that of an oval shape located in the scrotum, further separated by the scrotal septum. The length of the testis is between 3 cm to 5 cm, whereas the width is between 2 cm to 3 cm. The consistency of normal testicles on palpation is smooth and soft. The testes are suspended superiorly by the spermatic cord and inferior to the scrotum by the scrotal ligament. During embryological development, the scrotal ligament is also known as the gubernaculum. The tunica vaginalis is a double-layered structure that covers all of the testes apart from the posterior and superior borders, which represent the attachment of the epididymis and spermatic cord. The posterior lateral testis has a small space between the body of the epididymis and the testis. This small space is known as the sinus of the epididymis. The tunica albuginea is found deep to the tunica vaginalis. It is a thick fibrous sheath which covers the testes. The descent of the testicles is a complex stepwise process that involves an interaction between many anatomical structures, environmental influences, regulatory hormones, and inherited genetic factors.A choledochal cyst (CC) has traditionally been considered as a cystic dilation of the extrahepatic bile duct. https://www.selleckchem.com/products/bb-94.html Choledochal cysts are now termed biliary cysts to include intrahepatic cysts also. Biliary cysts are defined as cystic dilations involving the biliary tree at single or multiple segments of both the extrahepatic as well as intrahepatic bile ducts. In 1959 Alonso-LEJ et al. were the first to classify CC into 3 types based on the site of the biliary duct dilation. It was not until 1977 when Todani et al. modified the latter classification by adding 2 types of CCs. This five-category classification is the most commonly used by clinicians today; however, it is in dispute by some experts who claim that each type of CC has its natural course, complications, and management. It is proposed that a classification that focuses more on the pathogenesis rather than the simple anatomy of the biliary tree is recommended. Choledochal cyst is a rare anomaly that is, at times, considered a premalignant condition, which often poses a diagnostic dilemma. The typical presentation of this condition is non-specific. Healthcare teams must have a high clinical suspicion of choledochal cysts while investigating patients with jaundice, abdominal pain, and palpable abdominal mass. Due to the vague nature of these symptoms and physical findings, proper imaging studies are crucial for its diagnosis. Excision of the CC has shown excellent results with an 89% event-free rate and an overall 5-year survival rate above 90%. Hence early diagnosis and appropriate management are needed for optimal results and good prognosis.Fructose 1-phosphate aldolase deficiency or hereditary fruc­tose intol­er­ance (HFI) is an auto­so­mal reces­sive dis­order, caused by the deficiency in aldolase B (fructose-1, 6-bisphosphate aldolase), an enzyme responsible for the cleavage of fructose-1-phosphate. HFI is a metabolic disorder that usually manifests around 4-6 months of age when weaning is started. The inheritance pattern is autosomal recessive, and there is a 25% chance of having a child with HFI if both parents are heterozygotes. The mainstay of treatment is the dietary restriction of fructose, sorbitol, and sucrose. Life expectancy is normal in these individuals if appropriate precautionary measures are taken. The disorder leads to toxic accumulation of fructose-1-phosphate in the liver and renal tubules.Yellow nail syndrome (YNS) is a rare condition defined by a presence of two of the following (1) slow-growing, hard, yellow, and dystrophic nails, (2) lymphedema, and (3) respiratory tract disease. The earliest case of YNS was reported by Heller in 1927. However, in 1947, Samman & White published the first case series of YNS in patients with nail discoloration and lymphedema. Pulmonary disease, specifically pleural effusion, was added to the diagnostic criteria by Emerson in 1966. In general, the syndrome is acquired and affects adults over age 50. However, there are case reports of YNS occurring in children and even newborns. Anatomically, YNS affects the fingernails, toenails, the respiratory tract, and gravity-dependent areas that can accumulate fluid (typically lower extremities). These signs and symptoms are believed to be due to dysfunction in lymphatic drainage. Nails As the name suggests, xanthonychia (yellow nail coloration) is a common feature of YNS; however, yellow nails are not required if two ofymptoms of YNS can resolve without intervention. Unfortunately, many symptoms recur despite treatment and require continuous care. YNS has the potential to affect one's quality of life, including both cosmesis and worsening functional status. Recurring soft tissue infections (e.g., cellulitis from severe lymphedema), pulmonary infections (pneumonia/empyema), and pulmonary effusions can lead to complications such as antibiotic resistance, pulmonary scarring, and protein loss.Gyrate atrophy (GA) of the choroid and retina is a rare genetic disease of autosomal recessive inheritance. It primarily affects the ocular tissues and occurs due to deficiency of the enzyme ornithine aminotransferase that leads to a 10 to 20 times increase in the plasma level of the amino acid ornithine, compared to the normal plasma levels, that is thought to result in the ocular manifestations associated with the condition. This occurs due to mutations in the ornithine aminotransferase (OAT) gene located on chromosome 10, which results in a decrease or absence of the activity of the enzyme OAT. The condition is characterized by the development of chorioretinal atrophic patches that start in the mid-peripheral retina in the first decade and spread centrally to the macular area, myopia, changes in the macula including cystic changes that appear in the first and second decades, and posterior subcapsular cataracts. Patients usually present with night blindness followed by visual field constriction and eventually diminution of central vision and blindness.